Precigen (PGEN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Precigen (PGEN) is Neutral.

The composite score behind that read is -0.01, weighing +0.12 of bullish evidence against -0.16 bearish.

Precigen last closed at $8.54, +4.02% on the session.

Against the IVW growth benchmark the position is +3.05% over the forecast window.

The read is built from 11 underlying insights — 6 bullish and 5 bearish.

Agreement across those insights is 45%.

Precigen has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Precigen in the 1st percentile on return on equity, where 100 is best.

Precigen is classified under Health Care / Biotechnology, with a market capitalisation of $2.94B.

StockMap tracks Precigen as the 61st largest of the 250 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 124 Neutral, 117 Moderate Underperform, 8 Strong Underperform and 1 Moderate Outperform.

On that composite Precigen ranks 40th of 250 in the group, against a group median of -0.21.